Firering Strategic Minerals: From explorer to producer. Watch the video here.
All positive steps. Sitting and accumulating at these prices
Our chairman is ✈️ to #Singapore for the
@_TZMI_
Congress - the main event for #mineralsands. LB Group (the largest consumer of ilmenite) with whom we have offtake MoU are speaking: http://shorturl.at/jmJ46
We're looking forward to showcasing #SriLanka & the project.
Here is the link for anyone who hasn't seen it yet! Definitely worth the listen
https://youtu.be/X1PBMxLTH0k
Capital Metals (AIM: CMET), a mineral sands company approaching mine development stage at the high-grade
Eastern Minerals Project in Sri Lanka (the "Project"), will provide an update presentation and Q&A via the
Investor Meet Company platform on Thursday, 2 November 2023 at 11 a.m. GMT (“Webcast”). A PDF copy of
the presentation will be made available on the Company’s website at www.capitalmetals.com at or around 7.00
a.m. on 2 November 2023 and a recording of the Webcast will be made available on the website later that day.
The presentation follows the resumption of mine construction planning and is open to all existing and potential
shareholders. Questions can be submitted pre-event via your Investor Meet Company
(Alliance News) - Ondine Biomedical Inc on Tuesday said Alberta Health Services has expanded the use of its Steriwave naval photodisinfection technology following a successful pilot at the Mazankowski Alberta Heart Institute.
Shares in the Vancouver-based life sciences company jumped 23% to 12.90 pence each in London on Tuesday afternoon.
Ondine said after a successful pilot study at the Manzankowski Alberta Heart Institute, the device will now be used at the Royal Alexandra Hospital in Edmonton ahead of 3,000 planned orthopaedic surgeries in the next twelve months.
Last week, Ondine reported that Steriwave helped reduce spine surgery infection rates by 67% at Vancouver General Hospital, following an eight-year study conducted by VGH and University of British Columbia hospital.
Steriwave employs patented nasal photodisinfection technology to eliminate bacteria, fungi and viruses located on human tissues.
Chief Executive Officer Carolyn Cross said: "We are very pleased to be collaborating with Alberta Health Services to reduce the incidence of [surgical site infections] in Alberta without generating antibiotic resistance. The successful initial implementation of Steriwave into the pre-surgical treatment protocols at the Mazankowski Alberta Heart Institute has driven rapid adoption of Steriwave for orthopedic surgeries at the Royal Alexandra Hospital."
Mid Yorkshire Teaching NHS Trust has this week started the first UK pilot evaluation of nasal photodisinfection for the prevention of surgical site infections at Pontefract Hospital. The six-month pilot will see 500 elective hip and knee surgery patients nasally decolonized using Ondine Biomedical’s Steriwave® nasal photodisinfection prior to their surgery.
Steriwave is already in use at a number of hospitals across Canada, including Vancouver General Hospital and The Ottawa Hospital, and has demonstrated significant improvement in post-surgical outcomes including lower rates of infection, reduced patient length of stay, fewer readmissions, and lower rates of antibiotic prescribing.
Dr Stuart Bond, Consultant Antimicrobial Pharmacist & Director of Innovation at Mid Yorkshire Teaching NHS Trust commented: “We are very pleased to be the first NHS Trust in the UK to pilot this exciting, non-antibiotic method of preventing infections after surgery. Although infections after hip and knee surgeries are rare, we know that they lengthen patients’ stay in hospital, complicate the recovery process, and cause significant pain and suffering. We look forward to sharing the results of the Steriwave pilot in due course.”
Nasal decolonization is recommended by NICE to eliminate pathogens in a patient’s nasal cavities, like MRSA, which are major causes of SSIs. A patient with a surgical site infection will, on average, spend 7 to 11 days more in hospital, significantly increasing costs and lengthening patients’ recovery. Nasal mupirocin, an antibiotic, is usually used for nasal decolonization, however, there are serious concerns about its antimicrobial resistance rates which have been reported as high as 81%.
Nasal photodisinfection is a non-antibiotic method for nasal decolonization that uses a proprietary light-activated agent to destroy pathogens. First, the agent is applied to each nostril using a nasal swab, then the area is illuminated with a specific wavelength of light. The light activates the photodynamic agent, causing an oxidative burst that destroys pathogens. In this single, 5-minute treatment, Steriwave eliminates infection-causing bacteria, viruses and fungi in the nose.